Total Neoadjuvant Therapy (TNT) has significantly improved outcomes in locally advanced rectal cancer.
Despite rising use and inclusion in international guidelines, adoption patterns in Australia and New Zealand (ANZ) remain unclear.
This study determines bi-national patterns and predictors of TNT utilisation over a 6-year period.
